Antibiotics for recurrent acute pharyngo-tonsillitis: systematic review

  • Holger Munck
  • Anders W. Jørgensen
  • Tejs Ehlers Klug
Review
  • 50 Downloads

Abstract

The purpose was to determine the current evidence for preferable antibiotic treatment in three common clinical situations with insufficient consensus: Q1: Can antibiotic treatment prevent future attacks of acute pharyngo-tonsillitis (APT) in patients with recurrent APT (RAPT)? Q2: Which antibiotic regimen is preferable in the treatment of APT in patients with RAPT? Q3: Which antibiotic regimen is preferable in the treatment of relapsing APT? Five databases were searched systematically for randomized clinical trials on patients with RAPT with or without current APT or with relapse of APT. Of the unique publications, 643 were found. Five studies addressing Q1 (n = 3) and Q2 (n = 2) met the eligibility criteria. No studies reporting on Q3 were included. Q1: Two studies found that clindamycin and cefpodoxime, respectively, were effective in preventing future APT episodes and in eradicating group A streptococci from the tonsils of RAPT patients. One study found that long-term azithromycin had no effect on the number of APT episodes. Q2: Two studies reported superior clinical and microbiological effects of clindamycin and amoxicillin with clavulanate, respectively, compared to penicillin. The four studies showing superior effects of clindamycin and amoxicillin with clavulanate were assessed to have high risk of bias. Hence, the level of evidence was moderate. There is considerable evidence to suggest that clindamycin and amoxicillin with clavulanate are superior to penicillin with preferable effects on the microbiological flora and the number of future attacks of APT in patients with RAPT. Antibiotic treatment is an option in patients with RAPT, who has contraindications for tonsillectomy.

Keywords

Recurrent tonsillitis Antibiotics Amoxicillin with clavulanate Systematic review 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Schappert SM (1998) Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States. Vital Health Stat 13 134:1–37Google Scholar
  2. 2.
    Jones R (2004) Oxford textbook of primary medical care. Oxford University Press, Oxford, p 674Google Scholar
  3. 3.
    Johansson L, Mansson N-O (2003) Rapid test, throat culture and clinical assessment in the diagnosis of tonsillitis. Fam Pract 20(2):108–111CrossRefPubMedGoogle Scholar
  4. 4.
    Ehlers Klug T, Rusan M, Fuursted K et al (2009) Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscesses in Denmark. Clin Infect Dis 49(19):1467–1472CrossRefPubMedGoogle Scholar
  5. 5.
    Pelucchi C, Grigoryan L, Galeone C et al (2012) Guideline for the management of acute sore throat. Clin Microbiol Infect 18(Suppl 1):1–28CrossRefPubMedGoogle Scholar
  6. 6.
    De-Meyere M, Mervielde Y, Verschraegen G et al (1992) Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice. Eur J Clin Pharmacol 43:581–585CrossRefPubMedGoogle Scholar
  7. 7.
    Holm SE (1994) Reasons for failures in penicillin treatment of streptococcal tonsillitis and possible alternatives. Pediatr Infect Dis J 13(Supplement):66–74CrossRefGoogle Scholar
  8. 8.
    Paradise J (1981) Tonsillectomy and adenoidectomy. Pediatr Clin N Am 28(4):881–892CrossRefGoogle Scholar
  9. 9.
    AAO-HNS (2000) Clinical indicators: tonsillectomy, adenoidectomy, adenotonsillectomy. Clinical Indicators CompendiumGoogle Scholar
  10. 10.
    Georgalas CC, Tolley NS, Narula PA (2014) Tonsillitis. Clin Evid 22:2014Google Scholar
  11. 11.
    Baugh RF, Archer SM, Mitchell RB et al (2011) Clinical practice guideline: tonsillectomy in children. Otolaryngology-head and neck. Surgery 144(1 Suppl):1–30Google Scholar
  12. 12.
    Ng GJY, Tan S, Vu AN et al (2015) Antibiotics for preventing recurrent sore throat. Cochrane Database Syst Rev (7)Google Scholar
  13. 13.
    Morad A, Sathe N, Francis D et al (2017) Tonsillectomy versus watchful waiting for recurrent throat infection: a systematic review. Pediatrics 139(2):e20163490CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Brook I (1988) Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg 114(6):667–670CrossRefPubMedGoogle Scholar
  15. 15.
    Brook I (2017) Treatment challenges of group A beta-hemolytic streptococcal pharyngo-tonsillitis. Int Arch Otorhinolaryngol 21(03):286–296CrossRefPubMedGoogle Scholar
  16. 16.
    Higgins JPT, Green S (eds) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. [updated march 2011, cited 26 September 2017]. The Cochrane Collaboration. Available from www.cochrane-handbook.org
  17. 17.
    Schünemann H, Brożek J, Guyatt G et al (2013) GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE working group. Available from guidelinedevelopment.org/handbook (accessed 3 December 2017)
  18. 18.
    Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Altman D (1991) Practical statistics for medical research. Chapman and Hall, London. 10(10):1635–1636Google Scholar
  20. 20.
    Jensen JH, Larsen SB (1991) Treatment of recurrent acute tonsillitis with clindamycin. An alternative to tonsillectomy? Clin. Otolaryngology 16:498–500Google Scholar
  21. 21.
    Sirimanna KS, Madden GJ, Miles SM (1990) The use of long-acting penicillin in the prophylaxis of recurrent tonsillitis. J Otolaryngol 19(5):343–344PubMedGoogle Scholar
  22. 22.
    Brook I (1989) Medical treatment of non-streptococcal recurrent tonsillitis. Am J Otolaryngol 10:227–233CrossRefPubMedGoogle Scholar
  23. 23.
    Brook I (1989) Treatment of patients with acute recurrent tonsillitis due to group A β-haemolyric streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother 24:227–233CrossRefPubMedGoogle Scholar
  24. 24.
    Brook I, Hirokawa R (1985) Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. Clin Pediatr 24(6):331–336CrossRefGoogle Scholar
  25. 25.
    Lildholdt T, Doessing H, Lyster M et al (2003) The natural history of recurrent acute tonsillitis and a clinical trial of azithromycin for antibiotic prophylaxis. Clin Otolaryngol 28:371–373CrossRefPubMedGoogle Scholar
  26. 26.
    Mora R, Salami A, Mora F et al (2003) Efficacy of cefpodoxime in the prophylaxis of recurrent phrayngotonsillitis. Int J Pediatr Otolaryngol 67S1:225–228CrossRefGoogle Scholar
  27. 27.
    Standaert B, Finney K, Taylor M et al (1998) Comparison between cefprozil and penicillin to eradicate pharyngeal colonization of group A beta-hemolytic streptococci. Pediatr Infect Dis J 17(1):39–43CrossRefPubMedGoogle Scholar
  28. 28.
    Orrling A, Stjernquist-Desatnik A, Schalén C et al (1994) Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 26(5):535–541CrossRefPubMedGoogle Scholar
  29. 29.
    Orrling A, Stjernquist-Desatnik A, Schalen C (1997) Clindamycin in recurrent group A streptococcal pharyngotonsillitis—an alternative to tonsillectomy? Acta Otolaryngol 117(4):618–622CrossRefPubMedGoogle Scholar
  30. 30.
    Foote P, Brook I (1989) Penicillin and clindamycin therapy in recurrent tonsillitis: effect of microbial flora. Arch Otolaryngol Head Neck Surg 115(7):856–859CrossRefPubMedGoogle Scholar
  31. 31.
    Holm S, Henning C, Grahn E et al (1995) Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. Scand J Infect Dis 27(3):221–228CrossRefPubMedGoogle Scholar
  32. 32.
    Roos K, Larsson P (1997) Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scand J Infect Dis 29(2):141–145CrossRefPubMedGoogle Scholar
  33. 33.
    Mahakit P, Gil Vicente J, Igbal Butt D et al (2006) Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group A β-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther 28(1):99–109CrossRefPubMedGoogle Scholar
  34. 34.
    Roos K, Holm S, Grahn-Håkansson E, Lagergren L (1996) Recolonization with selected α-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis—a randomized placebo-controlled multicentre study. Scand J Infect Dis 28(5):459–462CrossRefPubMedGoogle Scholar
  35. 35.
    Ebenfelt A, Lundberg C (1994) Bacterial invasion of the tonsillar tissues in acute pharyngotonsillitis and in the adenoid: a preliminary study. Clin Otolaryngol 19(4):310–313CrossRefPubMedGoogle Scholar
  36. 36.
    Orrling A, Kamme C, Stjernquist-Desatnik A (2005) Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis. Scand J Infect Dis 37(6–7):429–435CrossRefPubMedGoogle Scholar
  37. 37.
    Kaplan EL, Chatwal GS, Rohde M (2006) Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 43:1398–1406CrossRefPubMedGoogle Scholar
  38. 38.
    Stjernquist-Desatnik A, Samuelsson P, Walder M (1993) Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol 107:309–312CrossRefPubMedGoogle Scholar
  39. 39.
    Österlund A, Popa R, Nikkilä T et al (1997) Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 107(5):640–647CrossRefPubMedGoogle Scholar
  40. 40.
    Neeman R, Keller N, Barzilai A et al (1998) Prevalence of internalization-associated gene, prtF1, among persisting group A streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974–1977CrossRefPubMedGoogle Scholar
  41. 41.
    McCarty J (1996) Azithromycin (Zithromax®). Infect Dis Obstet Gynecol 4(4):215–220CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Donowitz GR, Mandell GL (1988) Beta-lactam antibiotics. N Engl J Med 318:419–426CrossRefPubMedGoogle Scholar
  43. 43.
    Hackman A, Wilkins T (1975) In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother 7(5):698–703CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Brook I, Pazzaglia G, Coolbaugh J et al (1983) In vivo protection of group A β-haemolytic streptococci from penicillin by β-lactamase-producing Bacteroides species. J Antimicrob Chemother 12(6):599–606CrossRefPubMedGoogle Scholar
  45. 45.
    Brook I, Yocum P, Friedman EM (1981) Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol 90:261–263CrossRefPubMedGoogle Scholar
  46. 46.
    Tuner K, Nord C (1982) B-lactamase-producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother 10(suppl A):153–156CrossRefPubMedGoogle Scholar
  47. 47.
    Brook I, Foote P (1986) Comparison of the microbiology of recurrent tonsillitis between children and adults. Laryngoscope 96(12):1385CrossRefPubMedGoogle Scholar
  48. 48.
    Yildizoglu U, Polat B, Gumral R et al (2014) Effect of antibiotic use on bacterial flora of tonsil core in patients with recurrent tonsillitis. Eur Arch Otorhinolaryngol 272(6):1525–1528CrossRefPubMedGoogle Scholar
  49. 49.
    Burton M, Glasziou P (2009) Cochrane review: tonsillectomy or adeno-tonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis. Evid Based Child Health Cochrane Rev J 4(3):1291–1326CrossRefGoogle Scholar
  50. 50.
    Pro.medicin.dk (2017) Clindamycin “Alternova”. [online, updated 15 September 2017, accessed 27 Sep. 2017]. Available from: https://pro.medicin.dk/Medicin/Praeparater/3959

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology, Head and Neck SurgeryAarhus University HospitalAarhusDenmark

Personalised recommendations